Financials
- Market Capitalization 213.46 M
- Employee 30
- Founded 2014
- CEO N/A
- Website www.novabridge.com
- Headquarter Cayman Islands
- FIGI BBG00QQ8DFK6
- Industry Biotechnologies
Chiffre d'affaires total
Résultat net
Bénéfice par action de base (BPA de base)
Dette totale
Flux de trésorerie disponible
Trésorerie et équivalents de trésorerie
ratio cours/bénéfice
-8.29
ratio cours/chiffre d'affaires
876.63
Related tickers
| # | Nom | Prix | 24h % | 7 jours % | 1M % | 1 an % | Cap Boursière | 7 Derniers Jours | |
|---|---|---|---|---|---|---|---|---|---|
| 3597 | ABOS Acumen Pharmaceuticals, Inc. - Common Stock | 2.91 USD | -3.96% | -7.91% | +27.07% | +115.56% | 210.44 M USD | ||
| 3598 | IMUX Immunic, Inc. - Common Stock | 15.42 USD | -5.40% | -6.55% | +18.62% | +1652.27% | 210.40 M USD | ||
| 3606 | CUE Cue Biopharma, Inc. - Common Stock | 28.18 USD | +0.07% | +17.51% | -6.72% | +3422.50% | 204.71 M USD | ||
| 3608 | PLX Protalix BioTherapeutics, Inc. Common Stock | 2.53 USD | -3.07% | +6.75% | +7.20% | -13.36% | 203.85 M USD |